AR089309A1 - Metodos de diagnostico en mamiferos que presentan susceptibilidad incrementada a la erosion del esmalte - Google Patents

Metodos de diagnostico en mamiferos que presentan susceptibilidad incrementada a la erosion del esmalte

Info

Publication number
AR089309A1
AR089309A1 ARP120104802A ARP120104802A AR089309A1 AR 089309 A1 AR089309 A1 AR 089309A1 AR P120104802 A ARP120104802 A AR P120104802A AR P120104802 A ARP120104802 A AR P120104802A AR 089309 A1 AR089309 A1 AR 089309A1
Authority
AR
Argentina
Prior art keywords
level
enamel
film
erosion
staterin
Prior art date
Application number
ARP120104802A
Other languages
English (en)
Inventor
Proctor Gordon
Miller Steven
Zaidel Lynette
Carpenter Guy
Bartlett David
Moazzez Rebecca
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Publication of AR089309A1 publication Critical patent/AR089309A1/es

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/4721Cationic antimicrobial peptides, e.g. defensins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/4725Mucins, e.g. human intestinal mucin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/988Lyases (4.), e.g. aldolases, heparinase, enolases, fumarase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/18Dental and oral disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Métodos para identificar un mamífero que presenta una susceptibilidad incrementada a la erosión del esmalte. Conjuntos de elementos, usos y otros métodos basados en ellos. Reivindicación 1: Un conjunto de elementos (kit) para identificar pacientes susceptibles a la erosión de la dentina o del esmalte, caracterizado porque comprende (a) un dispositivo para obtener una muestra de la película adquirida del esmalte de la cavidad oral de un mamífero; (b1) una inmunotransferencia para analizar un parámetro de la saliva que se selecciona del grupo que consiste en el nivel de la mucina 5b, el nivel de la anhidrasa carbónica 6, el nivel de la estaterina, el nivel de la estaterina en la película 1 hora después de la adquisición y cualquier combinación de éstos; y/o (b2) un ensayo colorimétrico, un ensayo de espectrometría de masa con plasma de acoplamiento inductivo (ICP/MS) o un ensayo de absorción atómica para analizar el nivel del calcio en la película en la saliva 1 hora después de la adquisición; (c) una solución madre de BCA que comprende (i) ácido bicinconínico, (ii) carbonato de sodio, (iii) bicarbonato de sodio, (iv) tartrato de sodio y (v) pentahidrato de sulfato cúprico de sodio; y (d) instrucciones para identificar los pacientes susceptibles a la erosión de la dentina o del esmalte, donde la susceptibilidad se determina sobre la base de uno o más de los siguientes niveles: (i) un nivel de la mucina 5b inferior a 250 mg/ml, (ii) un nivel de la anhidrasa carbónica 6 inferior a 35 mg/ml, (iii) un nivel de la estaterina superior a 15 mg/ml, (iv) un nivel de la estaterina en la película 1 hora después de la adquisición inferior a 30 ng o (v) un nivel del calcio en la película 1 hora después de la adquisición inferior a 0,001 mol/mm².
ARP120104802A 2011-12-20 2012-12-18 Metodos de diagnostico en mamiferos que presentan susceptibilidad incrementada a la erosion del esmalte AR089309A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2011/066078 WO2013095367A1 (en) 2011-12-20 2011-12-20 Diagnostic methods

Publications (1)

Publication Number Publication Date
AR089309A1 true AR089309A1 (es) 2014-08-13

Family

ID=45507887

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP120104802A AR089309A1 (es) 2011-12-20 2012-12-18 Metodos de diagnostico en mamiferos que presentan susceptibilidad incrementada a la erosion del esmalte

Country Status (15)

Country Link
US (1) US9140708B2 (es)
EP (1) EP2795334B1 (es)
JP (1) JP2015507183A (es)
CN (1) CN103998936B (es)
AR (1) AR089309A1 (es)
AU (1) AU2011383728B2 (es)
BR (1) BR112014015040A2 (es)
CA (1) CA2858318A1 (es)
MX (1) MX349984B (es)
PH (1) PH12014501326A1 (es)
RU (1) RU2014129587A (es)
SG (1) SG11201402850YA (es)
TW (1) TWI471564B (es)
WO (1) WO2013095367A1 (es)
ZA (1) ZA201404276B (es)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7387774B2 (en) * 1999-11-12 2008-06-17 The Procter & Gamble Co. Method of enhancing fluoridation and mineralization of teeth
US6685920B2 (en) * 1999-11-12 2004-02-03 The Procter & Gamble Company Method of protecting teeth against erosion
WO2004089187A2 (en) * 2003-04-01 2004-10-21 University Of Southern California Caries risk test for predicting and assessing the risk of disease
JP2005331341A (ja) * 2004-05-19 2005-12-02 Horiba Ltd 口腔内健康維持能力の評価方法および評価装置
JP2007322124A (ja) * 2004-08-18 2007-12-13 Univ Nihon う蝕性リスクの判定方法及び判定薬
JP4426500B2 (ja) * 2005-04-28 2010-03-03 猛志 奥 歯のう蝕罹患リスクの評価方法及び装置並びにプログラム
EP2114989B1 (en) 2007-01-16 2016-04-06 Rutgers, the State University of New Jersey Natural polypeptides for oral health care

Also Published As

Publication number Publication date
PH12014501326A1 (en) 2014-10-20
AU2011383728A1 (en) 2014-06-19
ZA201404276B (en) 2016-03-30
CN103998936A (zh) 2014-08-20
EP2795334A1 (en) 2014-10-29
US20140348762A1 (en) 2014-11-27
CN103998936B (zh) 2016-03-23
RU2014129587A (ru) 2016-02-20
US9140708B2 (en) 2015-09-22
MX349984B (es) 2017-08-23
SG11201402850YA (en) 2014-10-30
TWI471564B (zh) 2015-02-01
MX2014007556A (es) 2014-08-01
TW201331584A (zh) 2013-08-01
AU2011383728B2 (en) 2014-09-04
CA2858318A1 (en) 2013-06-27
WO2013095367A1 (en) 2013-06-27
EP2795334B1 (en) 2016-09-28
BR112014015040A2 (pt) 2017-06-13
JP2015507183A (ja) 2015-03-05

Similar Documents

Publication Publication Date Title
Dai et al. Effects of fluoride and calcium phosphate materials on remineralization of mild and severe white spot lesions
Zuberi et al. Comparison of mean platelet volume in patients with diabetes mellitus, impaired fasting glucose and non-diabetic subjects
CL2013003000A1 (es) Composicion farmaceutica para el cuidado oral, que comprende una sal de calcio y una fuente de fosfato soluble; metodo para blanquear y remineralizar los dientes; y uso de dicha composicion en la remineralizacion, sensibilidad disminuida y/o blanqueamiento de los dientes y combinaciones de los mismos.
AR052851A1 (es) Composiciones dentifricas resisentes a la oxidacion
ECSP055859A (es) Forma cristalina alfa del renelato de estroncio, procedimiento para su preparacion y composiciones farmaceuticas que la contienen
BR112014000843A2 (pt) Uso de picosulfato para preparação de composição intestinal para o cálculo da duração de colonoscopia, composição intestinal e kit
Dukić et al. Caries prevalence in chronic alcoholics and the relationship to salivary flow rate and pH
Jakovac et al. Measurement of ion elution from dental ceramics
EA201300539A1 (ru) Твердая композиция для приема внутрь (варианты), способ терапевтической или нетерапевтической профилактики желудочно-кишечных расстройств или поддержания здорового состояния желудочно-кишечного тракта с ее помощью (варианты) и упаковка, ее содержащая
BR112014030680A2 (pt) forma de dosagem efervescente
AR089269A1 (es) Composiciones para el cuidado oral
AR098589A1 (es) Composiciones con zinc para el cuidado oral
ES2720869T3 (es) Composiciones farmacéuticas de sevelámero
RU2016124158A (ru) Композиция для ухода за полостью рта, содержащая серин и по меньшей мере соль цинка
AR089309A1 (es) Metodos de diagnostico en mamiferos que presentan susceptibilidad incrementada a la erosion del esmalte
UY31587A1 (es) Derivados de n-heterociclico-imidazo[1,2-a]piridina-2-carboxamidas, su preparacion y su aplicacion en terapéutica.
Wang et al. Dental plaque pH recovery effect of arginine bicarbonate rinse in vivo
Kim et al. The erosion of the tooth enamel and the cementum by carbonate beverage
BR112015016889A8 (pt) derivados de catecolamina enriquecidos com deutério em posição específica
MX2021007643A (es) Composiciones para el cuidado bucal y metodos de uso.
UY31586A1 (es) Derivados de n-fenil-imidazo[1,2-a]piridin-2-carboxamidas, su preparacion y su aplicacion en terapéutica
AR060426A1 (es) Nuevas sales de estroncio de acidos sulfonicos, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen
EP2749288A3 (en) Capsule and composition comprising seed oil
PA8643701A1 (es) Preparado de hierro ionico e hierro heminico y sus variantes en la profilaxis y tratamiento de la deficiencia de hierro
UY31590A1 (es) Derivados de n-heterociclico-6-heterociclico-imidazo[1,2-a]piridina-2-carboxamidas, su preparacion y su plicacion en terapéutica

Legal Events

Date Code Title Description
FB Suspension of granting procedure